Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conversion pharmacodynamic study of twice-daily Prograf to once-daily Envarsus in stable renal transplant patients
2015-005275-24Phase 4Active
- Sponsor
- Bellvitge University Hospital
- Start
- Feb 2016
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tacrolimus (2 arms), sponsored by Bellvitge University Hospital. Primary endpoint: Calcineurin activity AUC. Started Feb 2016; status: active.
02
Drugs
tacrolimus
Beyond the preview
Go deeper on 2015-005275-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005275-24.